Therapeutic Equivalence Trial of Two Hormonal-IUDs in Patients With Heavy Menstrual Bleeding

NCT01695902 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

280

Enrollment

INDUSTRY

Sponsor class

Conditions

Heavy Menstrual Bleeding

Interventions

DRUG: Levosert-20
DRUG: Mirena

Sponsor

Uteron Pharma S.A.